Table 1.
Clinical characteristics of 170 HCC patients and correlation with MAGL staining
| MAGL staining | |||
|---|---|---|---|
| Variables | Low (n = 77) n(%) | High (n = 93) n(%) | P |
| Gender | |||
| Male | 67 (87.0) | 78 (83.9) | 0.565 |
| Female | 10 (13.0) | 15 (16.1) | |
| Age(years) | |||
| ≤50 | 28 (36.4) | 37 (39.8) | 0.648 |
| >50 | 49 (63.6) | 56 (60.2) | |
| HBsAg | |||
| Negative | 14 (18.2) | 11 (11.8) | 0.244 |
| Positive | 63 (81.8) | 82 (88.2) | |
| HCV | |||
| Negative | 74 (96.1) | 91 (97.8) | 0.659 |
| Positive | 3 (3.9) | 2 (2.2) | |
| Liver cirrhosis | |||
| No | 30 (39.0) | 29 (31.2) | 0.289 |
| Yes | 47 (61.0) | 64 (68.8) | |
| AFP(ng/ml) | |||
| ≤20 | 28 (36.4) | 23 (24.7) | 0.099 |
| >20 | 49 (63.6) | 70 (75.3) | |
| Tumor number | |||
| Single | 56 (72.7) | 55 (59.1) | 0.064 |
| Multiple | 21 (27.3) | 38 (40.9) | |
| Tumor size(cm) | |||
| ≤5 | 44 (57.1) | 39 (41.9) | 0.048 |
| >5 | 33 (42.9) | 54 (58.1) | |
| Tumor encapsulation | |||
| Complete | 37 (48.1) | 49 (52.7) | 0.547 |
| Incomplete | 40 (51.9) | 44 (47.3) | |
| Microvascular invasion | |||
| Absent | 48 (62.3) | 42 (45.2) | 0.026 |
| Present | 29 (37.7) | 51 (54.8) | |
| Edmondson grade | |||
| I–II | 16 (20.8) | 36 (38.7) | 0.012 |
| III–IV | 61 (79.2) | 57 (61.3) | |
| TNM stage | |||
| I | 18 (23.4) | 5 (5.4) | 0.001 |
| II–III | 59 (76.6) | 88 (94.6) | |
HBsAg hepatitis B surface antigen, HCV hepatitis C virus, AFP alpha fetoprotein, TNM tumor node metastasis, MAGL monoacylglycerol lipase
Italic numbers means P < 0.05